Quick Answer
BELITE BIO, INC reported Earnings Per Share Diluted of $2.31 (loss) per share for the year ending 2025.
- BELITE BIO, INC showed a decrease of -95.8% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from BELITE BIO, INC's annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), BELITE BIO, INC's Earnings Per Share Diluted has declined by 255.4%.
- Historical annual values: Fiscal year 2025: $2.31 (loss) per share | Fiscal year 2024: $1.18 (loss) per share | Fiscal year 2023: $1.19 (loss) per share | Fiscal year 2022: $0.63 (loss) per share | Fiscal year 2021: $1.01 (loss) per share | Fiscal year 2020: $0.65 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: